Blaine Roberts
Affiliations: | Florey Institute of Neuroscience and Mental Health, University of Melbourne |
Google:
"Blaine Roberts"Children
Sign in to add trainee| Larissa Cristina Cavalho | grad student | 2016-2017 | Florey Institute of Neuroscience and Mental Health, University of Melbourne |
| Soumya Mukherjee | post-doc | 2017-2019 | Emory |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Montoliu-Gaya L, Bian S, Dammer EB, et al. (2025) Proteomic analysis of Down syndrome cerebrospinal fluid compared to late-onset and autosomal dominant Alzheimer´s disease. Nature Communications. 16: 6003 |
| Tandon R, Zhao L, Watson CM, et al. (2025) Stratifying risk of Alzheimer's disease in healthy middle-aged individuals with machine learning. Brain Communications. 7: fcaf121 |
| Guo Q, Ping L, Dammer EB, et al. (2024) Heparin-enriched plasma proteome is significantly altered in Alzheimer's disease. Molecular Neurodegeneration. 19: 67 |
| Guo Q, Ping L, Dammer EB, et al. (2024) Heparin-enriched plasma proteome is significantly altered in Alzheimer's Disease. Research Square |
| Schwinne M, Alonso A, Roberts BR, et al. (2024) The Association of Alzheimer's Disease-Related Blood-Based Biomarkers with Cognitive Screening Test Performance in the Congolese Population in Kinshasa. Journal of Alzheimer's Disease : Jad. 97: 1353-1363 |
| Odenkirk MT, Zheng X, Kyle JE, et al. (2024) Deciphering ApoE Genotype-Driven Proteomic and Lipidomic Alterations in Alzheimer's Disease Across Distinct Brain Regions. Journal of Proteome Research |
| Schwinne M, Alonso A, Roberts BR, et al. (2023) The Association of Alzheimer's Disease-related Blood-based Biomarkers with Cognitive Screening Test Performance in the Congolese Population in Kinshasa. Medrxiv : the Preprint Server For Health Sciences |
| Haque R, Watson CM, Liu J, et al. (2023) A protein panel in cerebrospinal fluid for diagnostic and predictive assessment of Alzheimer's disease. Science Translational Medicine. 15: eadg4122 |
| Johnson ECB, Bian S, Haque RU, et al. (2023) Cerebrospinal fluid proteomics define the natural history of autosomal dominant Alzheimer's disease. Nature Medicine |
| Modeste ES, Ping L, Watson CM, et al. (2023) Quantitative proteomics of cerebrospinal fluid from African Americans and Caucasians reveals shared and divergent changes in Alzheimer's disease. Molecular Neurodegeneration. 18: 48 |